Literature DB >> 23298959

What distinguishes adipose tissue of severely obese humans who are insulin sensitive and resistant?

X Julia Xu1, Walter J Pories, Lynis G Dohm, Neil B Ruderman.   

Abstract

PURPOSE OF REVIEW: Despite a strong correlation between obesity and insulin resistance, 25% of severely obese (BMI >40) individuals are insulin sensitive. In this review, we will examine the factors in adipose tissue that distinguish the two groups, as well as reasons for believing the insulin-sensitive group will be less disease prone. RECENT
FINDINGS: Obesity has been linked to the metabolic syndrome with an increase in visceral (intra-abdominal) compared to subcutaneous fat. Recent studies in which adipose tissue of insulin-sensitive and insulin-resistant patients with severe obesity were compared indicate that the insulin-resistant group is also distinguished by increases in oxidative stress and decreases in AMP-activated protein kinase (AMPK) activity. In contrast, changes in the expression of genes for SIRT1, inflammatory cytokines, mitochondrial biogenesis and function, and the two α-isoforms of AMPK showed more depot variation. Studies of how these and other changes in adipose tissue respond to bariatric surgery are still in their infancy.
SUMMARY: Available data suggest that increases in oxidative stress, decreases in AMPK activity and SIRT1 gene expression, depot-specific changes in inflammatory, mitochondrial and other genes distinguish adipose tissue of insulin resistant from insulin-sensitive individuals with severe obesity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298959      PMCID: PMC3575680          DOI: 10.1097/MOL.0b013e32835b465b

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  51 in total

1.  Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists.

Authors:  Andrea R Nawrocki; Michael W Rajala; Eva Tomas; Utpal B Pajvani; Asish K Saha; Myrna E Trumbauer; Zhen Pang; Airu S Chen; Neil B Ruderman; Howard Chen; Luciano Rossetti; Philipp E Scherer
Journal:  J Biol Chem       Date:  2005-12-02       Impact factor: 5.157

2.  The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women.

Authors:  G Hu; J Tuomilehto; K Silventoinen; N C Barengo; M Peltonen; P Jousilahti
Journal:  Int J Obes (Lond)       Date:  2005-08       Impact factor: 5.095

3.  Mitochondria are impaired in the adipocytes of type 2 diabetic mice.

Authors:  H-J Choo; J-H Kim; O-B Kwon; C S Lee; J Y Mun; S S Han; Y-S Yoon; G Yoon; K-M Choi; Y-G Ko
Journal:  Diabetologia       Date:  2006-02-25       Impact factor: 10.122

Review 4.  Are there persons who are obese, but metabolically healthy?

Authors:  E A Sims
Journal:  Metabolism       Date:  2001-12       Impact factor: 8.694

5.  AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.

Authors:  Jose M Cacicedo; Norito Yagihashi; John F Keaney; Neil B Ruderman; Yasuo Ido
Journal:  Biochem Biophys Res Commun       Date:  2004-11-26       Impact factor: 3.575

6.  Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo.

Authors:  Iwona Bogacka; Hui Xie; George A Bray; Steven R Smith
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

8.  Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

Authors:  Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

9.  High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

10.  Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.

Authors:  Asish K Saha; Paco R Avilucea; Ji Ming Ye; Murwarid M Assifi; Edward W Kraegen; Neil B Ruderman
Journal:  Biochem Biophys Res Commun       Date:  2004-02-06       Impact factor: 3.575

View more
  12 in total

1.  Effects of Chinese Fructus Mume formula and its separated prescription extract on insulin resistance in type 2 diabetic rats.

Authors:  Jing-Bin Li; Li-Jun Xu; Hui Dong; Zhao-Yi Huang; Yan Zhao; Guang Chen; Fu-Er Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

2.  Effects of Intentional Weight Loss on Markers of Oxidative Stress, DNA Repair and Telomere Length - a Systematic Review.

Authors:  Caroline Himbert; Henry Thompson; Cornelia M Ulrich
Journal:  Obes Facts       Date:  2017-12-14       Impact factor: 3.942

3.  Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease.

Authors:  Ajay P Belgaumkar; Royce P Vincent; Kirstin A Carswell; Robin D Hughes; Jamie Alaghband-Zadeh; Ragai R Mitry; Carel W le Roux; Ameet G Patel
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

4.  AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?

Authors:  X Julia Xu; Rudy J Valentine; Neil B Ruderman
Journal:  Curr Obes Rep       Date:  2014-06-01

5.  Improved Insulin Sensitivity 3 Months After RYGB Surgery Is Associated With Increased Subcutaneous Adipose Tissue AMPK Activity and Decreased Oxidative Stress.

Authors:  X Julia Xu; Caroline Apovian; Donald Hess; Brian Carmine; Asish Saha; Neil Ruderman
Journal:  Diabetes       Date:  2015-05-22       Impact factor: 9.461

6.  Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects.

Authors:  Michael B Zemel; Antje Bruckbauer
Journal:  Diabetes Metab Syndr Obes       Date:  2013-08-23       Impact factor: 3.168

Review 7.  AMPK, insulin resistance, and the metabolic syndrome.

Authors:  Neil B Ruderman; David Carling; Marc Prentki; José M Cacicedo
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

Review 8.  Mechanisms linking excess adiposity and carcinogenesis promotion.

Authors:  Ana I Pérez-Hernández; Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-01       Impact factor: 5.555

9.  Premenopausal Obesity and Breast Cancer Growth Rates in a Rodent Model.

Authors:  Shawna B Matthews; John N McGinley; Elizabeth S Neil; Henry J Thompson
Journal:  Nutrients       Date:  2016-04-11       Impact factor: 5.717

10.  Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus.

Authors:  Gay Carter; Branko Miladinovic; Achintya A Patel; Lauren Deland; Stephen Mastorides; Niketa A Patel
Journal:  BBA Clin       Date:  2015-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.